Circulating immune checkpoints predict heart failure outcomes

Circulating immune checkpoints predict heart failure outcomes

Abstract Aims There are limited data examining the role of immune checkpoint (IC) ligands in the pathophysiology of heart failure (HF). Therefore, we explore this in three HF animal models and in three different human cohorts (healthy, stable, and worsening HF). Methods and results Transcriptomic an...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	Elles M. Screever, Laura I.E. Yousif, Javid J. Moslehi, Joe‐Elie Salem, Adriaan A. Voors, Herman H.W. Silljé, Rudolf A. deBoer, Wouter C. Meijers
פורמט:	Article
שפה:	English
יצא לאור:	Wiley 2023-08-01
סדרה:	ESC Heart Failure
נושאים:	Immune checkpoints PD‐L1 PD‐L2 Galectin‐9 Heart failure
גישה מקוונת:	https://doi.org/10.1002/ehf2.14304

פריטים דומים

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study
מאת: Douglas B. Johnson, et al.
יצא לאור: (2019-05-01)

Checkpoint Inhibition in Myeloma: Opportunities and Challenges
מאת: Federica Costa, et al.
יצא לאור: (2018-09-01)

The role of immune checkpoints in cardiovascular disease
מאת: Laura I. Yousif, et al.
יצא לאור: (2022-10-01)

Enhancing cancer care with improved checkpoint inhibitors
מאת: Vickram A S, et al.
יצא לאור: (2024-10-01)

Checkmate with checkpoint inhibitors: New paradigm in immunotherapy
מאת: Ruby Dhar, et al.
יצא לאור: (2023-04-01)

Characterization of PD-1/PD-L1 Immune Checkpoint Expression in Osteosarcoma
מאת: Kazuhiko Hashimoto, et al.
יצא לאור: (2020-07-01)

Immune Checkpoint in Glioblastoma: Promising and Challenging
מאת: Jing Huang, et al.
יצא לאור: (2017-05-01)

Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy
מאת: Juwon Lee, et al.
יצא לאור: (2021-07-01)

Overview of the Cardiotoxicity Induced by PD-1/PD-L1 Immune Checkpoint Inhibitor in Critical Care
מאת: Ruiting Li, et al.
יצא לאור: (2021-06-01)

On Demand Biosensors for Early Diagnosis of Cancer and Immune Checkpoints Blockade Therapy Monitoring from Liquid Biopsy
מאת: Sai Mummareddy, et al.
יצא לאור: (2021-12-01)

PD-1/PD-L1 immune checkpoint inhibitors in glioblastoma: clinical studies, challenges and potential
מאת: Tianrui Yang, et al.
יצא לאור: (2021-02-01)

PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy
מאת: Jan Willem Kleinovink, et al.
יצא לאור: (2017-04-01)

Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression
מאת: Sebastian Marwitz, et al.
יצא לאור: (2017-05-01)

Immune Checkpoint Inhibitors in Cancer Therapy
מאת: Yavar Shiravand, et al.
יצא לאור: (2022-04-01)

Research Progress on Cardiotoxicity of PD-1/PD-L1 Immune Checkpoint Inhibitors
מאת: YU Lin, et al.
יצא לאור: (2021-08-01)

The Role of Immune Checkpoint Inhibitors in Cancer Therapy
מאת: Ahmed M. Basudan
יצא לאור: (2022-12-01)

The role of immune checkpoint inhibitors in prostate cancer
מאת: Gabriel Surdacki, et al.
יצא לאור: (2019-03-01)

Editorial: The Roles of Checkpoint Inhibitors in Inflammatory Diseases
מאת: Andreas von Knethen, et al.
יצא לאור: (2021-10-01)

Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis
מאת: Alberto Bongiovanni, et al.
יצא לאור: (2021-05-01)

Predictive Biomarkers of Immune Checkpoint Inhibitors-Related Toxicities
מאת: Ya Xu, et al.
יצא לאור: (2020-10-01)

Structural Characterization of a Macrocyclic Peptide Modulator of the PD-1/PD-L1 Immune Checkpoint Axis
מאת: Edyta Zyla, et al.
יצא לאור: (2021-08-01)

The Neonatal Innate Immune Response to Sepsis: Checkpoint Proteins as Novel Mediators of This Response and as Possible Therapeutic/Diagnostic Levers
מאת: Emily Hensler, et al.
יצא לאור: (2022-07-01)

Key questions about the checkpoint blockade-are microRNAs an answer?
מאת: Mihnea Dragomir, et al.
יצא לאור: (2018-06-01)

Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer
מאת: Maria Georganaki, et al.
יצא לאור: (2018-12-01)

Enhancement of anti-tumor efficacy of immune checkpoint blockade by alpha-TEA
מאת: William L. Redmond, et al.
יצא לאור: (2023-02-01)

The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors
מאת: Reid P. Bissonnette, et al.
יצא לאור: (2021-08-01)

Advances in immune checkpoint inhibitors for hepatocellular carcinoma
מאת: Ji Won Han, et al.
יצא לאור: (2021-09-01)

Immune Checkpoint Inhibitors: Ctla-4 and Pd-1/Pd-l1 in Immunotherapy
מאת: Kübra KAHVECİ, et al.
יצא לאור: (2019-12-01)

Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation
מאת: Zachary S. Buchwald, et al.
יצא לאור: (2018-12-01)

Safety and efficacy of PD-1/PD-L1 immune checkpoint inhibitors in patients with pre-treated advanced stage malignant mesothelioma: a systematic review and meta-analysis
מאת: Amjad Zafar, et al.
יצא לאור: (2024-11-01)

The impact of antibiotic use on clinical features and survival outcomes of cancer patients treated with immune checkpoint inhibitors
מאת: Jiaxin Zhou, et al.
יצא לאור: (2022-07-01)

Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
מאת: Adel Naimi, et al.
יצא לאור: (2022-04-01)

Editorial: Biomarkers of Immune-Checkpoint-Inhibitor Immunotherapies in Hepatocellular Carcinomas
מאת: Zhanjun Guo, et al.
יצא לאור: (2022-03-01)

Profiling targetable immune checkpoints in osteosarcoma
מאת: Troy A McEachron, et al.
יצא לאור: (2018-12-01)

The Use of Phytochemicals to Improve the Efficacy of Immune Checkpoint Inhibitors: Opportunities and Challenges
מאת: Deniz Can Guven, et al.
יצא לאור: (2022-10-01)

Commentary: Chronic PD-1 Checkpoint Blockade Does Not Affect Cognition or Promote Tau Clearance in a Tauopathy Mouse Model
מאת: Kuti Baruch, et al.
יצא לאור: (2020-05-01)

NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy
מאת: Leona Raskova Kafkova, et al.
יצא לאור: (2024-02-01)

Efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer
מאת: Shuai Wang, et al.
יצא לאור: (2018-08-01)

PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells
מאת: Silvia Pesce, et al.
יצא לאור: (2019-06-01)

In Search of Better Peptide-(Derived from PD-L2)-Based Immune Checkpoint Inhibitors
מאת: Boris Klebansky, et al.
יצא לאור: (2024-05-01)